top of page


January 12, 2021

Endospan Enrolls First Patient in TRIOMPHE IDE Study

April 20, 2020

FDA Grants NEXUS™ Aortic Arch Stent Graft System Breakthrough Designation

September 12, 2019

Endospan Enters Into Strategic Distribution Agreement With CryoLife

May 14, 2018

Endospan elects Jeff Elkins as a Director

March 21, 2018

Endospan receives CE mark for HORIZON™ EVAR system based on robust clinical and pivotal data to treat Abdominal Aortic Aneurysm (AAA)

March 12, 2018

Endospan appoints Kevin J. Mayberry as CEO

CAUTION: Investigational Device – Limited by United States law to investigational use. Endospan devices bear the CE marking of conformity.
bottom of page